Fowler, J. S., Logan, J., Volkow, N. D., Shumay, E., McCall-Perez, F., Jayne, M., . . . Muench, L. (2015). Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain. Neuropsychopharmacology.
Citação norma ChicagoFowler, Joanna S., et al. "Evidence That Formulations of the Selective MAO-B Inhibitor, Selegiline, Which Bypass First-Pass Metabolism, Also Inhibit MAO-A in the Human Brain." Neuropsychopharmacology 2015.
Citação norma MLAFowler, Joanna S., et al. "Evidence That Formulations of the Selective MAO-B Inhibitor, Selegiline, Which Bypass First-Pass Metabolism, Also Inhibit MAO-A in the Human Brain." Neuropsychopharmacology 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.